Effect of the contents and form of rabies glycoprotein on the potency of rabies vaccination in cattle

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 2, 2002, Pages 265-268

  Piza, A T ^a   Pieri, K M S ^b   Lusa, G M ^b   Caporale, G M M ^c   Terreran, M T ^a   Machado, L A ^a   Zanetti, C R ^b  

^a VALLÉE S A   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c Instituto Pasteur de Sao Paulo   (Brazil)

Author keywords

Cattle vaccination; NIH test; Rabies; Rabies glycoprotein

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; RABIES VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CATTLE; CATTLE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MOUSE; RABIES; SERODIAGNOSIS; STANDARD;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; MICE; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; VIRAL ENVELOPE PROTEINS;

EID: 1642306197     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762002000200022     Document Type: Article

References (24)

1. Adamowicz P, Aguilon F, David A, Le Fur R, Mazert MC, Perrin P, Reculard P, Sureau P 1983. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures. Dev Biol Stand 55: 191-197.
2. Astoul E, Lafage M, Lafon M 1996. Rabies superantigen as a Vb T-dependent adjuvant. J Exp Med 183: 1623-1631.
3. Aubert, MFA 1996. Methods for the calculation of titers. In F-X Meslin, MM Kaplan, H Koprowski (eds), Laboratory Techniques in Rabies, 4th ed., World Health Organization, Geneva, p. 445-459.
4. Celis E, Ou D. Dietzschold B, Koprowski H 1988. Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients. J Virol 62: 3128-3134.
5. Côrtes JA, Rweyemamu MM, Ito FH, Umehara O, Medeiros Neto RR, De Lucca-Neto D, Baltazar MC, Vasconcellos SA, Vasconcellos MEP 1993. Immune response in cattle induced by inactivated rabies vaccine adjuvanted with aluminium hydroxide either alone or in combination with avridine. Rev Scitech Offint Epiz 12: 941-955.
6. Crick J, Brown F 1978. Questions concerning the potency of rabies vaccine. Dev Biol Stand 40: 179.
7. Dietzschold B 1993. Antibody-mediated clearance of viruses from the mammalian central nervous system. Trends Microbiol 1: 63-66.
8. Dietzschold B, Wang H, Rupprecht C, Celis E, Tollis M, Erttl H. Heber-Katz E, Koprowski H 1987. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA 84: 9165-9169.
9. Dietzschold B, Wiktor TJ, Wunner WH, Varrichio A 1983. Chemical and immunological analysis of the rabies soluble glycoprotein. Virology 124: 330-337.
10. Drings A, Jallet C, Chambert B, Tordo N, Perrin P1999. Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine? Vaccine 17: 1549-1557.
11. Favoretto SR, Carrieri ML, Tino MS, Zanetti CR, Pereira OAC 1993. Simplified fluorescent inhibition microtest for the titration of rabies neutralizing antibodies. Rev Inst Med Trop São Paulo 35: 171-175.
12. Habel K1996. Habel test for potency. In F-X Meslin, MM Kaplan, H Koprowski (eds), Laboratory Techniques in Rabies, 4th ed., World Health Organization, Geneva, p. 369-373.
13. Hooper C, Pierard I, Modelska A, Otvos L, Fu Z, Koprowski H, Dietzschold B 1994. Rabies nucleocapsid as na oral immunogen and immunological enhancer. Proc Natl Acad Sci USA 91: 10908-10912.
14. Koprowski H 1996. Guinea-pig potency test for chicken-embryo vaccine. In F-X Meslin, MM Kaplan. H Koprowski (eds), Laboratory Techniques in Rabies, 4th ed., World Health Organization, Geneva, p. 374-377.
15. Larghi OP, Nebel AE 1985. Duration of immunity afforded to cattle by binary-ethylenimine inactivated rabies vaccine. Zbl Vet Med B 32: 609-615.
16. Linhart SB, Flores RC, Mitchell G 1972. Control de murciélagos vampires por medio de un anticoagulante. Bol Ofic Sanit Panamer 63:100.
17. Perrin P, Lafon M, Sureau P 1996. Enzyme-linked immuno-sorbent assay (ELISA) for the determination of the giycoprotein content of rabies vaccine. In F-X Meslin, MM Kaplan, H Koprowski (eds), Laboratory Techniques in Rabies. 4th ed., World Health Organization, Geneve, p. 383-387.
18. Perrin P, Thibodeau L, Sureau P 1985. Rabies immunosomes (sub-unit vaccines) structure and immunogenicity. Pre- and post-exposure protection studies. Vaccine 3: 325-32.
19. Rodrigues da Silva A, Caporale GMM, Gonçalves CA, Targueta MC, Comin F, Zanetti CR, Kotait I 2000. Antibody response in cattle after vaccination with inactivated and attenuated rabies vaccine. Rev Inst Med Trop São Paulo 42: 95-98.
20. Schumacher CL, Dietzschold B, Ertl HC, Niu HS, Rupprecht CE, Koprowski H 1989. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest 84: 971-975.
21. Wiktor T, Gyorgy E, Schlumberger D, Sokol F, Koprowski H 1973. Antigenic properties of rabies virus components. J Immunol 110: 269-276.
22. Wilbur LA, Aubert MFA 1996. The NIH test for potency. In: F-X Meslin, MM Kaplan , H Koprowski(eds),1996. Laboratory Techniques in Rabies, 4th ed., World Health Organization, Geneva, p. 360-368.
23. Wunderli PS, Shaddock JH, Schmid DS, Miller TJ, Baer GM 1991. The protective role of humoral neutralinzing anti-body in the NIH potency test for rabies vaccines. Vaccine 9: 638-642.
24. Zanetti CR, De Franco MT, Vassão RC, Pereira CA, Pereira OAP 1998. Failure of protection induced by a Brazilian vaccine against Brazilian wild rabies viruses. Arch Virol 143: 1745-1756.